We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

BIO-RAD LABORATORIES

Provides full range of instrumentation, reagent kits, software and quality control systems to clinical laboratories. ... read more Featured Products: More products

Download Mobile App




Events

09 Apr 2024 - 12 Apr 2024
15 Apr 2024 - 17 Apr 2024
23 Apr 2024 - 26 Apr 2024

ddPCR Developed for BCR-ABL1 Fusion Transcript in B-Lymphoblastic Leukemia

By LabMedica International staff writers
Posted on 12 Jan 2022
Print article
Image: QX200 AutoDG ddPCR System and QXDx BCR-ABL %IS Kit (Photo courtesy of Bio-Rad)
Image: QX200 AutoDG ddPCR System and QXDx BCR-ABL %IS Kit (Photo courtesy of Bio-Rad)
Droplet digital polymerase chain reaction (ddPCR) is a novel polymerase chain reaction (PCR) technique reliant on massive sample partitioning to generate individual reaction chambers (droplets) in which individual amplification targets are detected.

Standardized measurements of BCR-ABL1 p210 translocation by RT-qPCR assays for chronic myelogenous leukemia have proved challenging because of various sources of error including processing of specimens, reference gene selection, the reverse transcriptase reaction, and quantification of transcripts.

Medical Scientists at the University of Minnesota (Minneapolis, MN, USA) obtained clinical samples from specimens from patients who had been previously tested for BCR-ABL1 p190 transcript in the molecular diagnostics laboratory. Samples consisted of both bone marrow and peripheral blood. All samples were stored at −80 °C. The scientists’ aim was to compare results of ddPCR and RT-qPCR BCR-ABL1 fusion transcript measurements of patient samples and determine if either method is superior.

RNA was isolated with the Maxwell RSC simplyRNA Blood Kit and Maxwell RCS instrument (Promega, Madison, WI, USA). The clinical RT-qPCR assay was performed using the TaqMan Reverse Transcription and TaqMan Universal PCR Master Mix (Applied Biosystems, Waltham, MA, USA). Droplet digital PCR was performed using the One-Step RT-ddPCR Advanced Kit for Probes and for automated studies, the QX200 AutoDG system (Bio-Rad Laboratories, Hercules, CA, USA). The PCR was performed in a Bio-Rad C1000 Touch thermal cycler.

The investigators reported that droplet digital polymerase chain reaction was able to detect the BCR-ABL1 p190 transcript to 0.001% (1:10−5) with a calculated limit of detection and limit of quantitation of 4.1 and 5.3 transcripts, respectively. When tested on patient samples, ddPCR was able to identify 20% more positives than a laboratory-developed 2-step RT-qPCR assay. Of the 101 samples measured, 65 samples with a previously positive p190 transcript and sufficient RNA for analysis were further analyzed. Thirty-five of 65 samples (54%) were measured as positive by both methods, and the BCR-ABL1:ABL1 ratio was compared. The majority of samples showed concordant results between the two methods, but several samples demonstrated discordant quantification.

The authors concluded that droplet digital polymerase chain reaction demonstrated increased detection of BCR-ABL1 compared with RT-qPCR. Improved detection of BCR-ABL1 p190 and the potential for improved standardization across multiple laboratories makes ddPCR a suitable method for disease monitoring in patients with acute B-lymphoblastic leukemia. The study was published in the January, 2022 issue of the journal Archives of Pathology and Laboratory Medicine.

Related Links:
University of Minnesota
Promega
Applied Biosystems
Bio-Rad Laboratories


Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Specimen Collection & Transport
Complement 3 (C3) Test
GPP-100 C3 Kit
New
Gold Member
Plasma Control
Plasma Control Level 1

Print article

Channels

Clinical Chemistry

view channel
Image: Reaching speeds up to 6,000 RPM, this centrifuge forms the basis for a new type of inexpensive, POC biomedical test (Photo courtesy of Duke University)

POC Biomedical Test Spins Water Droplet Using Sound Waves for Cancer Detection

Exosomes, tiny cellular bioparticles carrying a specific set of proteins, lipids, and genetic materials, play a crucial role in cell communication and hold promise for non-invasive diagnostics.... Read more

Molecular Diagnostics

view channel
Image: The cobas Malaria test is the first FDA-approved molecular test to screen U.S. blood donors for malaria (Photo courtesy of Roche)

First FDA-Approved Molecular Test to Screen Blood Donors for Malaria Could Improve Patient Safety

Malaria, a serious illness that often leads to death, is spread by a specific mosquito species that infect humans with a parasite. Other transmission modes include blood transfusions, organ transplants,... Read more

Pathology

view channel
Image: The medical office procedure detects the key biomarker in Parkinson’s and related neurodegenerative diseases (Photo courtesy of BIDMC)

Simple Skin Biopsy Test Detects Parkinson’s and Related Neurodegenerative Diseases

Parkinson's disease and a group of related neurodegenerative disorders known as synucleinopathies impact millions globally. These conditions, including Parkinson’s disease (PD), dementia with Lewy bodies... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.